These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 12152225)

  • 1. Evaluation of endothelin-converting enzyme inhibitors using cultured cells.
    Corder R
    Methods Mol Biol; 2002; 206():147-64. PubMed ID: 12152225
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring reactive oxygen species inhibition of endothelin-converting enzyme.
    Lowenstein CJ
    Methods Enzymol; 2002; 353():263-8. PubMed ID: 12078501
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of a novel aspartyl endothelin converting enzyme in porcine aortic endothelial cells.
    Knap AK; Soriano A; Savage P; Del Grande D; Shetty SS
    Biochem Mol Biol Int; 1993 Mar; 29(4):739-45. PubMed ID: 8490580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of endothelin-converting enzyme inhibitors for the treatment of cardiovascular diseases.
    Jeng AY
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1076-81. PubMed ID: 14582451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelins are potent vasoconstrictors, and much more besides.
    Gray GA; Battistini B; Webb DJ
    Trends Pharmacol Sci; 2000 Feb; 21(2):38-40. PubMed ID: 10733432
    [No Abstract]   [Full Text] [Related]  

  • 6. Design and synthesis of diversely substituted azacyclic inhibitors of endothelin converting enzyme.
    Hanessian S; Gauchet C; Charron G; Marin J; Nakache P
    J Org Chem; 2006 Mar; 71(7):2760-78. PubMed ID: 16555831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and assessment of endothelin-converting enzyme activity.
    Jackson CD; Turner AJ
    Methods Mol Biol; 2002; 206():107-24. PubMed ID: 12152223
    [No Abstract]   [Full Text] [Related]  

  • 8. Daleformis, a new phytoalexin from the roots fo Dalea filiciformis: an inhibitor of endothelin converting enzyme.
    Patil AD; Freyer AJ; Eggleston DS; Haltiwanger RC; Tomcowicz B; Breen A; Johnson RK
    J Nat Prod; 1997 Mar; 60(3):306-8. PubMed ID: 9157193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-converting enzyme inhibitors for the treatment of subarachnoid hemorrhage-induced vasospasm.
    Lin CL; Winardi W; Jeng AY; Kwan AL
    Neurol Res; 2006 Oct; 28(7):721-9. PubMed ID: 17164035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guinea pig Clara cells secrete endothelin 1 through a phosphoramidon-sensitive pathway.
    Laporte J; D'Orléans-Juste P; Sirois P
    Am J Respir Cell Mol Biol; 1996 Apr; 14(4):356-62. PubMed ID: 8600940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMC-66, a new endothelin converting enzyme inhibitor produced by Streptomyces sp. A5008.
    Asai Y; Nonaka N; Suzuki S; Nishio M; Takahashi K; Shima H; Ohmori K; Ohnuki T; Komatsubara S
    J Antibiot (Tokyo); 1999 Jul; 52(7):607-12. PubMed ID: 10513839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel, selective indole-based ECE inhibitors: lead optimization via solid-phase and classical synthesis.
    Brands M; Ergüden JK; Hashimoto K; Heimbach D; Schröder C; Siegel S; Stasch JP; Weigand S
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4201-5. PubMed ID: 16085415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple method for isolating human endothelin converting enzyme free from contamination by neutral endopeptidase 24.11.
    Corder R; Khan N; Harrison VJ
    Biochem Biophys Res Commun; 1995 Feb; 207(1):355-62. PubMed ID: 7857289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel selective quinazoline inhibitors of endothelin converting enzyme-1.
    Ahn K; Sisneros AM; Herman SB; Pan SM; Hupe D; Lee C; Nikam S; Cheng XM; Doherty AM; Schroeder RL; Haleen SJ; Kaw S; Emoto N; Yanagisawa M
    Biochem Biophys Res Commun; 1998 Feb; 243(1):184-90. PubMed ID: 9473502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and degradation of endothelin-1.
    D'Orléans-Juste P; Plante M; Honoré JC; Carrier E; Labonté J
    Can J Physiol Pharmacol; 2003 Jun; 81(6):503-10. PubMed ID: 12839262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Of mice and men: advances in endothelin research and first antagonist gains FDA approval.
    Davenport AP; Maguire JJ
    Trends Pharmacol Sci; 2002 Apr; 23(4):155-7. PubMed ID: 11931980
    [No Abstract]   [Full Text] [Related]  

  • 17. Metallopeptide-promoted inactivation of angiotensin-converting enzyme and endothelin-converting enzyme 1: Toward dual-action therapeutics.
    Gokhale NH; Cowan JA
    J Biol Inorg Chem; 2006 Oct; 11(7):937-47. PubMed ID: 16874470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endothelin and kidney disease].
    Nakayama Y; Tomita K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():655-60. PubMed ID: 15506468
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of a phostone glycomimetic of the endothelin converting enzyme inhibitor phosphoramidon.
    Hanessian S; Rogel O
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2441-6. PubMed ID: 10476884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of endothelin-converting enzyme activities in ARPE-19 cells, a human retinal pigmented epithelial cell line.
    Dibas A; Prasanna G; Yorio T
    J Ocul Pharmacol Ther; 2005 Jun; 21(3):196-204. PubMed ID: 15969636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.